Funded Tech Companies
Tessa Therapeutics
Tessa Therapeutics is a biopharmaceutical company, based in Singapore. Investment came from private investors, Edbi and Temasek Holdings.
Company Overview
Company Name
Tessa Therapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
8 Temasek Boulevard, #24-02 Suntec Tower 3
Singapore, 038988
Singapore
Singapore, 038988
Singapore
Phone
Website
Email Address
Company Background Information
Overview
Tessa Therapeutics is a clinical-stage biotechnology company developing a portfolio of novel next-generation cell therapies for cancer. Tessa is leading the way in CD30 targeting using cell therapy. CD30 is a well validated lymphoma target with homogenous expression in Classical Hodgkin Lymphoma and multiple subsets of non-Hodgkin Lymphomas. Tessa's approach to target CD30-positive cancers using CAR-T (Chimeric Antigen Receptor) cells has demonstrated excellent safety and efficacy in early clinical trials. Having received the RMAT and PRIME designation, Tessa is now advancing the therapy to a pivotal trial.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
7/6/2023
Financing History
Management Team
Title
Name
Email & Social
Chairman
Göran Ando
Chief Executive Officer
John Ng
Chief Financial Officer
Wilson Cheung
Chief Medical Officer
Ivan Horak
Company Investors
- Edbi
- Temasek Holdings
- Polaris Partners (Amy Schulman)
- Heliconia Capital Management
- Heritas Capital Management
Browse more funded tech companies:
Share this article
About Our Venture Capital Transactions Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs